Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H L Elliott

Showing results (91-100 of 249) with videos related to

Pageof 25
Sort By:
British Journal of Clinical Pharmacology|August 1, 1986
The pharmacodynamics and dose-response relationships of the angiotensin converting enzyme inhibitor, cilazapril, in essential hypertensionA A Ajayi, H L Elliott, J L Reid
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|December 1, 1989
Pressor responsiveness, age and hypertensionD J Sumner, C A Howie, H L Elliott
British Journal of Clinical Pharmacology|January 1, 1983
The pharmacokinetics of mianserinM Shami, H L Elliott, A W Kelman, et al.
Annals of the New York Academy of Sciences|July 12, 1995
Clinical pharmacology of drugs acting on imidazoline and adrenergic receptors. Studies with clonidine, moxonidine, rilmenidine, and atenololJ L Reid, V Panfilov, G MacPhee, et al.
Blood Pressure. Supplement|January 1, 1994
Pharmacokinetics of spirapril in renal impairmentP A Meredith, P Grass, C Guitard, et al.
Journal of Cardiovascular Pharmacology|November 1, 1990
Clinical studies with the potassium channel activator cromakalim in normotensive and hypertensive subjectsR Donnelly, H L Elliott, P A Meredith, et al.
European Journal of Clinical Pharmacology|February 19, 1979
Alterations of phenytoin protein binding with in vivo haemodialysis in dialysis encephalopathyW H Steele, J R Lawrence, H L Elliott, et al.
British Journal of Clinical Pharmacology|August 1, 1993
R-verapamil: pharmacokinetics and effects on PR interval, blood pressure and heart rateJ H Ahmed, J Godden, P A Meredith, et al.
The American Journal of Medicine|January 5, 1987
Clinical pharmacology of selective alpha blockers. Hemodynamics and effects on lipid levelsJ L Reid, H L Elliott, J Vincent, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|December 1, 1985
The effect of calcium channel blockers on alpha 1- and alpha 2-adrenoceptor-mediated vascular responsiveness in manH L Elliott, F Pasanisi, D J Sumner, et al.
Pageof 25

Showing results (91-100 of 249) with videos related to

Sort By:
Pageof 25
British Journal of Clinical Pharmacology|August 1, 1986
The pharmacodynamics and dose-response relationships of the angiotensin converting enzyme inhibitor, cilazapril, in essential hypertensionA A Ajayi, H L Elliott, J L Reid
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|December 1, 1989
Pressor responsiveness, age and hypertensionD J Sumner, C A Howie, H L Elliott
British Journal of Clinical Pharmacology|January 1, 1983
The pharmacokinetics of mianserinM Shami, H L Elliott, A W Kelman, et al.
Annals of the New York Academy of Sciences|July 12, 1995
Clinical pharmacology of drugs acting on imidazoline and adrenergic receptors. Studies with clonidine, moxonidine, rilmenidine, and atenololJ L Reid, V Panfilov, G MacPhee, et al.
Blood Pressure. Supplement|January 1, 1994
Pharmacokinetics of spirapril in renal impairmentP A Meredith, P Grass, C Guitard, et al.
Journal of Cardiovascular Pharmacology|November 1, 1990
Clinical studies with the potassium channel activator cromakalim in normotensive and hypertensive subjectsR Donnelly, H L Elliott, P A Meredith, et al.
European Journal of Clinical Pharmacology|February 19, 1979
Alterations of phenytoin protein binding with in vivo haemodialysis in dialysis encephalopathyW H Steele, J R Lawrence, H L Elliott, et al.
British Journal of Clinical Pharmacology|August 1, 1993
R-verapamil: pharmacokinetics and effects on PR interval, blood pressure and heart rateJ H Ahmed, J Godden, P A Meredith, et al.
The American Journal of Medicine|January 5, 1987
Clinical pharmacology of selective alpha blockers. Hemodynamics and effects on lipid levelsJ L Reid, H L Elliott, J Vincent, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|December 1, 1985
The effect of calcium channel blockers on alpha 1- and alpha 2-adrenoceptor-mediated vascular responsiveness in manH L Elliott, F Pasanisi, D J Sumner, et al.
Pageof 25